Cite

HARVARD Citation

    Raghav, K. et al. (2020). Defining a Distinct Immunotherapy Eligible Subset of Patients with Cancer of Unknown Primary Using Gene Expression Profiling with the 92‐Gene Assay. Oncologist. pp. e1807-e1811. [Online]. 
  
Back to record